Tibet Aim Pharm
¥9.35
0
+¥0+0% Today
Statistics
Day High
9.46
Day Low
9.26
52W High
13.28
52W Low
5.57
Volume
1,921,300
Avg. Volume
4,586,689
Mkt Cap
2.05B
P/E Ratio
44.71
Dividend Yield
0.32%
Dividend
0.03
Upcoming
31
MAY 25
Dividend Ex
Estimated
31
MAY 25
Dividend Payment
Estimated
31
MAY 26
Dividend Ex
Estimated
31
MAY 26
Dividend Payment
Estimated
Dividends
0.32%Dividend Yield
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
-27.89%
1Y Growth
-70%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 002826.SZ. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Tibet AIM Pharm. Inc. engages in the research and development of medical products in China. The company's products include Miglitol tablets for diabetes; Gualoupi injection for coronary disease; Oxytocin injection for gynecology and obstetrics; NalMefene injection for various acute poisoning, such as alcohol, organic phosphor, CO, sedative-hypnotic, opioid substance, serious infection, shock, fainting, and brain; Carbetocin injections; and Hongjin Xiaojie tablets and Aceclofenac Enteric-Coated tablets, as well as for the treatment of antibiotic, antiallergic, and digestive system. Tibet AIM Pharm. Inc. was founded in 2003 and is headquartered in Beijing, China.
Show more...
CEO
Mr. Ke Xu
Country
CN
ISIN
CNE100002C39